Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000892569-07-001387
Filing Date
2007-11-08
Accepted
2007-11-08 16:23:13
Documents
7
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a35324e10vq.htm 10-Q 784324
2 EXHIBIT 3.3 a35324exv3w3.htm EX-3.3 6131
3 EXHIBIT 15.1 a35324exv15w1.htm EX-15.1 3436
4 EXHIBIT 15.2 a35324exv15w2.htm EX-15.2 1665
5 EXHIBIT 31.1 a35324exv31w1.htm EX-31.1 6240
6 EXHIBIT 31.2 a35324exv31w2.htm EX-31.2 6207
7 EXHIBIT 32.1 a35324exv32w1.htm EX-32.1 5193
  Complete submission text file 0000892569-07-001387.txt   814781
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
VALEANT PHARMACEUTICALS INTERNATIONAL (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11397 | Film No.: 071226135
SIC: 2834 Pharmaceutical Preparations